Back to Search
Start Over
Evidence for rCBV as an early response marker following bevacizumab treatment.
- Source :
-
Neuro-oncology [Neuro Oncol] 2015 Nov; Vol. 17 (11), pp. 1539-40. - Publication Year :
- 2015
Details
- Language :
- English
- ISSN :
- 1523-5866
- Volume :
- 17
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Neuro-oncology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 26453577
- Full Text :
- https://doi.org/10.1093/neuonc/nov199